Whereas IRE1 and PERK pathways can induce changes in autophagy-related markers such as increased Atg5, LC3-II, etc., to promote autophagy, which inhibits ERS-induced apoptosis in tumour cells. The gene discussed is ATG5; the disease is neoplasm.